Sunny
祥翊製藥股份有限公司
Sunny is a Taiwan Emerging Stock Board biotechnology company; its most advanced asset is Diazepam Injection (FDA ANDA approved, Anxiety), as of 2026-11-01.
Pipeline
| Asset | Target / mechanism | Stage | Indication | Region | Source date | Source |
|---|---|---|---|---|---|---|
| Diazepam Injection | — | FDA ANDA approved | Anxiety | United States | 2025-01-03 | Company disclosure |
Key events
No verified events in the past twelve months.
Related Drugnews articles
No related articles in this language.